Newsletters

Catch up on our latest newsletters - curated updates, insights, and news delivered to you.

The Limits of the Molecule: Why Complex Neurological Conditions Demand a Different Approach

Our second issue examines why serious neurological conditions resist pharmacological solutions and why the answer is biological, not scientific. The pathology in conditions like Alzheimer's, treatment-resistant depression, and TBI resides in neural circuit organization, making circuit-level intervention not a last resort, but the conceptually appropriate response.

Read the full brief →

Issue No. 2

Past Issues

What's being published, what regulators are signaling, and what it means for neuroscience investors and drug developmers

Selected publications, regulatory developments, and industry events — with independent scientific interpretation from the SignalNeuro Partners team

News & Insights